Evidence map›Paper›PMID 32887553›Full record

ArticleBMC psychiatry2020

Predictors of response to exposure and response prevention-based cognitive behavioral therapy for obsessive-compulsive disorder.

Sayo Hamatani, Aki Tsuchiyagaito, Masato Nihei, Yuta Hayashi, Tokiko Yoshida, Jumpei Takahashi, Sho Okawa, Honami Arai, Maki Nagaoka, Kazuki Matsumoto and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in BMC psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05841017 (Effectiveness of the Immersive Virtual Reality in the Psychological Treatment of Obsessive Compulsive Disorder), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05841017 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Effectiveness of the Immersive Virtual Reality in the Psychological Treatment of Obsessive Compulsive Disorder

TypeinterventionalSponsorConsorci Hospitalari de VicRan2023 to 2024Enrolled98ConditionsObsessive-Compulsive DisorderArmsPsychotherapy with Immersive Virtual Reality support.
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sayo HamataniResearch Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.
Aki TsuchiyagaitoResearch Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.
Masato NiheiResearch Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.
Yuta HayashiDepartment of Cognitive Behavioral Physiology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Tokiko YoshidaResearch Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.
Jumpei TakahashiResearch Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.
Sho OkawaGraduate School of Medicine and Veterinary Medicine, University of Miyazaki, Miyazaki, Japan.
Honami AraiResearch Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.
Maki NagaokaResearch Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.
Kazuki MatsumotoResearch Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.
Eiji ShimizuResearch Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan.
Yoshiyuki HiranoResearch Center for Child Mental Development, Chiba University, Inohana, Chuo-ku, Chiba, 2608670, Japan. hirano@chiba-u.jp.ORCID 0000-0003-3844-3061

Funding

Japan Agency for Medical Research and Development JP20dm0307002Japan Society for the Promotion of Science 16K04342Japan Society for the Promotion of Science 16K04344Japan Society for the Promotion of Science 19J00227Japan Society for the Promotion of Science 19K03309
6 · The paper itself

Abstract

backgroundCognitive behavioral therapy (CBT), which includes exposure and response prevention (ERP), is effective in improving symptoms of obsessive-compulsive disorder (OCD). However, whether poor cognitive functions and autism spectrum disorder (ASD) traits affect the therapeutic response of patients with OCD to ERP-based CBT remains unclear. This study aimed to identify factors predictive of the therapeutic response of Japanese patients with OCD to ERP-based CBT.

methodsForty-two Japanese outpatients with OCD were assessed using the Wechsler Adult Intelligence Scale-III (WAIS-III), Yale-Brown Obsessive-Compulsive Scale, Patient Health Questionnaire 9-item scale, and Autism Spectrum Quotient (AQ) at pre- and post-treatment. We used multiple regression analyses to estimate the effect on therapeutic response change. The treatment response change was set as a dependent variable in multiple regression analyses.

resultsMultiple regression analyses showed that among independent variables, communication as an AQ sub-scale and Letter Number Sequencing as a WAIS-III sub-test predict the therapeutic response to ERP-based CBT .

conclusionsOur results suggest that diminished working memory (Letter Number Sequencing), poor communication skill (AQ sub-scale) may undermine responsiveness to ERP-based CBT among patients with OCD.

trial registrationUMIN, UMIN00024087 . Registered 20 September 2016 - Retrospectively registered (including retrospective data).

Indexed as

Autism Spectrum DisorderCognitive Behavioral TherapyObsessive-Compulsive DisorderAdultCognitionHumansRetrospective StudiesTreatment OutcomeCognitive behavioral therapyExposure and response preventionObsessive-compulsive disorderTherapeutic response

Identifiers

PMID32887553
PMCPMC7473813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.